Denali Therapeutics
DNLI | NASDAQ
$18.08
-$0.66 (-3.52%)
At close: Nov 16, 2026, 4:00 PM ET
$18.08
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Denali Therapeutics Statistics
Key statistics explainedMarket Data
$3.41B
$2.91B
1.08
1.66M
192.08M
11.4%
84.07%
NASDAQ
US24823R1059
Price Performance
2.7%
-25.8%
-1.7%
9.5%
4.1%
-3.6%
-63.3%
2.7%
3.7%
-18.0%
-1.5%
Valuation
-10.45
N/A
-0.26
0.27
159.30
20.70
3.68
-7.57
-6.27
-7.83
136.31
-7.58
-5.81
-6.48
-9.6%
-13.2%
-15.9%
Financial Health
$491.47M
$24.73M
$516.2M
$1.26B
6.21
5.94
0.26
-0.05
-0.06
-17.96
0.00
3.41
2
Margins & Profitability
72.0%
-2488.1%
-1409.9%
-1470.5%
-2104.5%
-2538.6%
434.1%
-20.6%
Returns
-25.0%
-34.0%
-45.4%
-45.8%
-25.7%
Historical Growth (CAGR)
-60.3%
-42.9%
0.8%
20.9%
-2.3%
4.3%
-9.0%
-12.4%
-29.3%
Analyst Forecasts
Buy
11
9.8%
171.8%
Feb 25, 2027
-$0.61
-16.4%
$31.66M
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$34.00
88.1%
Cash Flow
$-444.19M
$-449.99M
$-542.8M
-$2.34
-$2.31
-2077.4%
Income Statement
$21.38M
$-2.2M
$-532.01M
$-501.92M
$-314.42M
-$1.73
$42.51K
$-625.1K
503
Add to Watchlist
Select watchlists to add or remove DNLI